Table of Contents

Acute Myeloblastic Leukemia

Epidemiology

Etiology

Manifestations

Diagnosis

Classification

Genomics

Risk Stratification

Risk category Management
Poor Treatment → transplant complex karyotype, TP53
Intermediate Treatment → transplant
Favorable Treatment, no transplant t(15,17) or APL

* Usually allogeneic transplant

Evaluation

Treatment

Supportive care

Acute Promyeoblastic Leukemia